SXTC SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jul 1, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jul 31, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 13, 2024

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Jul 31, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jul 31, 2023

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

May 19, 2023

News

TYPE

HEADLINE

FILED AT

6-K

Purchasers Terminate Right to Acquire Up to $12 Million in Additional Shares or Pre-Funded Warrants; Offering Securities Unaffected

Oct 21, 2026

6-K

China SXT Pharmaceuticals Announces Registered Direct Offering of $12 Million

Oct 9, 2026

6-K

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

Oct 8, 2026

6-K

China SXT Pharmaceuticals Terminates Private Placement Offering

Oct 8, 2026

6-K

China SXT Pharmaceuticals Amends Securities Purchase Agreement to Reduce Floor Price

Aug 28, 2026

6-K

China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering

Jul 24, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Oct 9, 2026

424B5

REGISTERED OFFERING

Jul 24, 2026

424B5

[No Baby Shelf]* June 2026 ATM | Offering amount: $100,000,000 | Bank: Univest Securities, LLC

Jun 1, 2026

424B5

REGISTERED OFFERING

Apr 9, 2026

424B5

REGISTERED OFFERING

Jan 12, 2026

424B5

REGISTERED OFFERING

May 19, 2025

Registrations

TYPE

HEADLINE

FILED AT

F-3/A

SHARE RESALE REGISTRATION + SPA

Aug 28, 2026

F-3

SHARE RESALE REGISTRATION

Jul 7, 2026

F-3

November 2025 SHELF

Nov 10, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Nov 10, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 28, 2025

F-3

SHELF | Offering amount: $120,000,000.00 | Amount sold to date: $0.00 EFFECTIVE

Oct 22, 2024

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

Orca Capital AG (Filed by)

Oct 15, 2026

Pan Xiaodong Sean (Reporting)

Apr 27, 2026

Zhou Feng Felix (Reporting)

Apr 27, 2026

Chee Yong Lip (Reporting)

Apr 27, 2026

Ji Xiaodong (Reporting)

Apr 27, 2026

Liu Tong Tony (Reporting)

Apr 27, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 17, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 17, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 5, 2024

CORRESP

Form CORRESP - Correspondence

Nov 1, 2024

LETTER

Form UPLOAD - SEC-generated letter

Oct 30, 2024

LETTER

Form UPLOAD - SEC-generated letter

Jun 2, 2023

China SXT Pharmaceuticals, Inc. SXTC · SEC Filings